1268618-16-1

Basic information

• Product Name: (S)-5-guanidino-2-({3-[5-(3-{[(1H-pyrazol-3-ylmethyl)-amino]-methyl}-phenyl)-2,3-dihydro-benzofuran-7-sulfonylamino]-thiophene-2-carbonyl}-amino)-pentanoic acid
• CAS NO: 1268618-16-1
• Molecular Weight: 666.782
• Mol File: 1268618-16-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (S)-5-guanidino-2-({3-[5-(3-{[(1H-pyrazol-3-ylmethyl)-amino]-methyl}-phenyl)-2,3-dihydro-benzofuran-7-sulfonylamino]-thiophene-2-carbonyl}-amino)-pentanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-5-guanidino-2-({3-[5-(3-{[(1H-pyrazol-3-ylmethyl)-amino]-methyl}-phenyl)-2,3-dihydro-benzofuran-7-sulfonylamino]-thiophene-2-carbonyl}-amino)-pentanoic acid(1268618-16-1)
• EPA Substance Registry System: (S)-5-guanidino-2-({3-[5-(3-{[(1H-pyrazol-3-ylmethyl)-amino]-methyl}-phenyl)-2,3-dihydro-benzofuran-7-sulfonylamino]-thiophene-2-carbonyl}-amino)-pentanoic acid(1268618-16-1)

Safety Data

• Hazardous Substances Data: 1268618-16-1(Hazardous Substances Data)

Upstream product

• 1268618-43-4 3-(5-bromo-2,3-dihydrobenzofuran-7-sulfonylamino)thiophene-2-carboxylic acid 
• 1268618-42-3 3-(5-bromo-2,3-dihydrobenzofuran-7-sulfonylamino)thiophene-2-carboxylic acid methyl ester 
• 22288-78-4 Methyl 3-aminothiophene-2-carboxylate 
• 690632-00-9 5-bromo-2,3-dihydrobenzofuran-7-sulfonyl chloride 
• 1268618-50-3 N2-(3-((5-(3-formylphenyl)-2,3-dihydrobenzofuran)-7-sulfonamido)thiophene-2-carbonyl)-Nω-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)-L-arginine 
• 1268618-45-6 (S)-2-{[3-(5-bromo-2,3-dihydrobenzofuran-7-sulfonylamino)thiophene-2-carbonyl]amino}-5-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-sulfonylguanidino)pentanoic acid 
• 1268618-44-5 (S)-2-{[3-(5-bromo-2,3-dihydrobenzofuran-7-sulfonylamino)thiophene-2-carbonyl]amino}-5-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-sulfonylguanidino)pentanoic acid methyl ester 

Relevant articles and documents

Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells

We report the design, synthesis, and biological evaluation of some potent small-molecule neuropilin-1 (NRP1) antagonists. NRP1 is implicated in the immune response to tumors, particularly in Treg cell fragility, required for PD1 checkpoint blockade. The d